Evofosfamide

http://dbpedia.org/resource/Evofosfamide an entity of type: Thing

Evofosfamide (INN, USAN; formerly known as TH-302) is an investigational hypoxia-activated prodrug that is in clinical development for cancer treatment. The prodrug is activated only at very low levels of oxygen (hypoxia). Such levels are common in human solid tumors, a phenomenon known as tumor hypoxia. Evofosfamide is being evaluated in clinical trials for the treatment of multiple tumor types as a monotherapy and in combination with chemotherapeutic agents and other targeted cancer drugs. Dec 2015 : two Phase 3 trials fail, Merck will not apply for a license rdf:langString
rdf:langString Evofosfamide
xsd:integer 18438985
xsd:integer 1110203928
rdf:langString Evofosfamide.svg
xsd:integer 200
rdf:langString TH-302; HAP-302
rdf:langString methyl N,N′-bisphosphorodiamidate
xsd:integer 631058729
rdf:langString Evofosfamide (INN, USAN; formerly known as TH-302) is an investigational hypoxia-activated prodrug that is in clinical development for cancer treatment. The prodrug is activated only at very low levels of oxygen (hypoxia). Such levels are common in human solid tumors, a phenomenon known as tumor hypoxia. Evofosfamide is being evaluated in clinical trials for the treatment of multiple tumor types as a monotherapy and in combination with chemotherapeutic agents and other targeted cancer drugs. Dec 2015 : two Phase 3 trials fail, Merck will not apply for a license
xsd:nonNegativeInteger 59727
rdf:langString TH-302; HAP-302
rdf:langString (1-Methyl-2-nitro-1H-imidazol-5-yl)methyl N,N′-bis(2-bromoethyl)phosphorodiamidate
owl:Thing
<http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#ChemicalObject>
dbpedia-owl:ChemicalSubstance
<http://www.wikidata.org/entity/Q11173>
yago:WikicatMolecularFormulas
yago:Abstraction100002137
yago:Agent109190918
yago:Agent114778436
yago:Antineoplastic102722458
yago:CausalAgent100007347
yago:Communication100033020
yago:CytotoxicDrug103157987
yago:Drug103247620
yago:Formula106816935
yago:Matter100020827
yago:Medicine103740161
yago:Message106598915
yago:MolecularFormula106817173
yago:PhysicalEntity100001930
dbpedia-owl:ChemicalCompound
dbpedia-owl:Drug
yago:Statement106722453
yago:Substance100020090
yago:WikicatAlkylatingAntineoplasticAgents
yago:WikicatExperimentalCancerDrugs
<http://commons.wikimedia.org/wiki/Special:FilePath/Evofosfamide.svg>
<http://commons.wikimedia.org/wiki/Special:FilePath/TH-302_Activation_and_Mechanism_of_action.png>
<http://dbpedia.org/resource/Category:Alkylating_antineoplastic_agents>
<http://dbpedia.org/resource/Category:Organobromides>
<http://dbpedia.org/resource/Category:Prodrugs>
<http://dbpedia.org/resource/Category:Experimental_cancer_drugs>
<http://dbpedia.org/resource/Category:Nitroimidazoles>
<http://dbpedia.org/resource/Category:Nitrogen_mustards>
<http://dbpedia.org/resource/Category:Phosphorodiamidates>
<http://dbpedia.org/resource/Category:Bromoethyl_compounds>
<http://dbpedia.org/resource/Category:Merck_brands>
<http://dbpedia.org/resource/Protein-bound_paclitaxel>
<http://dbpedia.org/resource/Bis(2-ethylhexyl)_phthalate>
<http://dbpedia.org/resource/Category:Alkylating_antineoplastic_agents>
<http://dbpedia.org/resource/Category:Organobromides>
<http://dbpedia.org/resource/Category:Prodrugs>
<http://dbpedia.org/resource/Response_Evaluation_Criteria_in_Solid_Tumors>
<http://dbpedia.org/resource/Gemcitabine>
<http://dbpedia.org/resource/Category:Experimental_cancer_drugs>
<http://dbpedia.org/resource/Category:Nitroimidazoles>
<http://dbpedia.org/resource/Apoptosis>
<http://dbpedia.org/resource/Pancreatic_cancer>
<http://dbpedia.org/resource/Prodrug>
<http://dbpedia.org/resource/Progression-free_survival>
<http://dbpedia.org/resource/Tumor_hypoxia>
<http://dbpedia.org/resource/Water_for_injection>
<http://dbpedia.org/resource/Category:Nitrogen_mustards>
<http://dbpedia.org/resource/Category:Phosphorodiamidates>
<http://dbpedia.org/resource/Cyclophosphamide>
<http://dbpedia.org/resource/Cytotoxin>
<http://dbpedia.org/resource/Doxorubicin>
<http://dbpedia.org/resource/Erlotinib>
<http://dbpedia.org/resource/Ethanol>
<http://dbpedia.org/resource/File:TH-302_Activation_and_Mechanism_of_action.png>
<http://dbpedia.org/resource/PVC>
<http://dbpedia.org/resource/Category:Bromoethyl_compounds>
<http://dbpedia.org/resource/Pharmaceutical_formulation>
<http://dbpedia.org/resource/International_Nonproprietary_Name>
<http://dbpedia.org/resource/Hypoxia_(medical)>
<http://dbpedia.org/resource/Category:Merck_brands>
<http://dbpedia.org/resource/Chemotherapy>
<http://dbpedia.org/resource/Superoxide>
<http://dbpedia.org/resource/Dimethylacetamide>
<http://dbpedia.org/resource/Azole>
<http://dbpedia.org/resource/Polysorbate_80>
<http://dbpedia.org/resource/Hypoxia-activated_prodrugs>
<http://dbpedia.org/resource/Ifosfamide>
<http://dbpedia.org/resource/Mechanism_of_action>
<http://dbpedia.org/resource/United_States_Adopted_Name>
<http://dbpedia.org/resource/FOLFIRINOX>
<http://dbpedia.org/resource/Reimbursement>
<http://dbpedia.org/resource/Merck_KGaA>
<http://dbpedia.org/resource/Structure-activity_relationship>
<http://dbpedia.org/resource/Dextrose>
<http://dbpedia.org/resource/Soft_tissue_sarcoma>
<http://dbpedia.org/resource/Overall_survival>
<https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-004072-30/ES>
<http://clinicaltrials.gov/show/NCT00061984>
<http://clinicaltrials.gov/show/NCT00495144>
<http://clinicaltrials.gov/show/NCT00742963>
<http://clinicaltrials.gov/show/NCT00743379>
<http://clinicaltrials.gov/show/NCT00844649>
<http://clinicaltrials.gov/show/NCT01144455>
<http://clinicaltrials.gov/show/NCT01149915>
<http://clinicaltrials.gov/show/NCT01381822>
<http://clinicaltrials.gov/show/NCT01403610>
<http://clinicaltrials.gov/show/NCT01440088>
<http://clinicaltrials.gov/show/NCT01485042>
<http://clinicaltrials.gov/show/NCT01497444>
<http://clinicaltrials.gov/show/NCT01522872>
<http://clinicaltrials.gov/show/NCT01721941>
<http://clinicaltrials.gov/show/NCT01746979>
<http://clinicaltrials.gov/show/NCT01833546>
<http://clinicaltrials.gov/show/NCT01864538>
<http://clinicaltrials.gov/show/NCT02020226>
<http://clinicaltrials.gov/show/NCT02047500>
<http://clinicaltrials.gov/show/NCT02076230>
<http://clinicaltrials.gov/show/NCT02093962>
<http://clinicaltrials.gov/show/NCT02255110>
<http://clinicaltrials.gov/show/NCT02342379>
<http://rdf.freebase.com/ns/m.04dzx18>
<http://yago-knowledge.org/resource/Evofosfamide>
<http://www.wikidata.org/entity/Q7670203>
<http://sh.dbpedia.org/resource/TH-302>
<http://sr.dbpedia.org/resource/TH-302>
<https://global.dbpedia.org/id/4vNCi>
<http://dbpedia.org/resource/Template:COI>
<http://dbpedia.org/resource/Template:Chembox>
<http://dbpedia.org/resource/Template:Chembox_Hazards>
<http://dbpedia.org/resource/Template:Chembox_Identifiers>
<http://dbpedia.org/resource/Template:Chembox_Properties>
<http://dbpedia.org/resource/Template:Citation_needed>
<http://dbpedia.org/resource/Template:Color>
<http://dbpedia.org/resource/Template:Expand_section>
<http://dbpedia.org/resource/Template:More_citations_needed>
<http://dbpedia.org/resource/Template:Multiple_issues>
<http://dbpedia.org/resource/Template:Reflist>
<http://dbpedia.org/resource/Template:Update>
<http://dbpedia.org/resource/Template:Cascite>
<http://dbpedia.org/resource/Template:Chemspidercite>
<http://dbpedia.org/resource/Template:Fdacite>
<http://dbpedia.org/resource/Template:Keggcite>
<http://dbpedia.org/resource/Template:Stdinchicite>
<http://commons.wikimedia.org/wiki/Special:FilePath/Evofosfamide.svg?width=300>
<http://dbpedia.org/resource/Prodrug>
<http://en.wikipedia.org/wiki/Evofosfamide?oldid=1110203928&ns=0>
<http://en.wikipedia.org/wiki/Evofosfamide>

data from the linked data cloud